about
Novel approaches to inhibition of gastric acid secretionOxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in ratsOrally administered L-arginine and glycine are highly effective against acid reflux esophagitis in ratsEvidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapyReview of esomeprazole in the treatment of acid disorders.Gastric function measurements in drug developmentReview of rabeprazole in the treatment of gastro-oesophageal reflux disease.Review article: trials on reflux disease -- the role of acid secretion and inhibition.Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders.Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.Interactions between protease inhibitors and acid-reducing agents: a systematic review.A randomized, crossover pharmacodynamic study of immediate-release omeprazole/sodium bicarbonate and delayed-release lansoprazole in healthy adult volunteers.A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD).Treatment and chemoprevention of NSAID-associated gastrointestinal complications.A Multicenter, Randomized, Open-Label Trial: Efficacy of Once-Daily Versus Twice-Daily Double-Dose Rabeprazole on Refractory Gastroesophageal Reflux Disease-Related Symptoms and Quality of Life.Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.Esomeprazole: potent acid suppression in the treatment of acid-related disorders.Clinically significant drug interactions with antacids: an update.Evolving pharmacological approaches in gastroesophageal reflux disease.Animal model of acid-reflux esophagitis: pathogenic roles of acid/pepsin, prostaglandins, and amino acidsHistamine2-receptor antagonists: Rapid development of tachyphylaxis with repeat dosing.Role of gastroesophageal reflux disease in lung transplantation.Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole.Acid suppression in healthy subjects following lansoprazole or pantoprazole.Ameliorative and antioxidant effects of myrtle berry seed (Myrtus communis) extract during reflux-induced esophagitis in rats.Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.Intrinsic resistance triggered under acid loading within normal esophageal epithelial cells: NHE1- and ROS-mediated survival.H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.Acid control with esomeprazole and lansoprazole: a comparative dose-response study.Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells.Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B.Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease.
P2860
Q24614255-12D38561-4472-42EC-B376-1811BF49A679Q28346258-88599787-6722-4A81-817C-68FA16AA619FQ28709325-FBBF70A9-762E-4798-8EA0-2611FE0A64FCQ30249468-48EE4F57-17D5-410F-A1C2-216A9FB3C287Q31404948-4D17995E-74A2-474E-A952-D6258ED830E3Q34831226-EECE67BF-D1E2-4BE4-A6CA-CB9B644D0BD4Q35058137-24FA2F2F-DB3C-41FD-8324-461BF94A8D79Q35190650-8F8E8049-DE54-4B0D-9A0C-4AA5E50B29CAQ35609697-FD260B2A-46F6-4D6D-8961-D71E204D3A96Q35904891-074DFD98-5695-49AD-A623-5EDDA65C812CQ35923949-27D8D954-8359-49CE-B4CD-777AE6C6C2A9Q35923959-FA767CE1-D29D-464D-967E-76391D853A1FQ35923964-C6BB2F8F-42AC-4DA8-B77B-E4D846AF14B0Q36301601-E5A2778E-8D49-49A6-949A-0D88B53C9D1BQ36319521-A51F1BE4-9A59-4406-A3A2-1030ADAD8A33Q36895942-4DF61408-8D37-415B-8C3F-11D278A7098BQ36924620-BC2C6959-A479-4D43-B286-8E0A71C65C65Q37160360-384699BA-0756-414C-93A8-F9563A0C638CQ37230285-00A62424-5E5C-40AB-933F-B7571E319209Q37545323-FD6B02B6-2FF9-4DB3-8099-F5887E4AB884Q37745066-8F0148C9-4843-4687-8A61-0FB58EF7D045Q37755220-88F808EB-722C-4E9B-973C-B5A3C4ED30DBQ37937722-62B72756-0ABD-4EE0-ABD2-CA2A2B5D21D9Q38029727-484E26D1-5E48-4E12-9D23-D0B9518A7C11Q38199694-216D1ED3-619F-41EB-9A23-A2C13BC30311Q38215517-9A3D6C4A-222B-48EE-BFEF-08E1E8548D58Q38784394-92C35689-B064-4598-98FD-0D4DEDEEEC46Q38861693-FFFDCA99-DC54-4F02-B44A-95BDB5265848Q39377527-D2823E6C-C4E4-423F-8995-BBFED13B3797Q39409890-C1046828-8398-4C72-8865-DB179AC1070AQ40061714-365EF8CA-8DD0-4428-B2DD-E1813FE16600Q41074387-F6731DEE-6F4F-407C-BA97-ABB1C5C74500Q41560226-B6077155-766F-474A-8AEA-8944E88A5793Q41672575-D4BED803-3950-462D-99EC-C4785E326B99Q42165562-A5536386-FD4E-4AB9-B8B9-818BDA1E8612Q42613192-6AD4B11D-D2D7-4BC3-9C1A-FAB502E9EB03Q42760591-CFE0E45E-D6E1-4562-8E8F-1D48BC5FFA98Q42923401-125B94F6-AECC-4E9C-99F7-75A42E317C62Q43244695-6E5913BB-DE17-46E9-95F5-78AEE977D9FDQ44761476-BD04074D-ACBB-411F-B7FA-C91D52CB9230
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Importance of pH control in the management of GERD.
@ast
Importance of pH control in the management of GERD.
@en
type
label
Importance of pH control in the management of GERD.
@ast
Importance of pH control in the management of GERD.
@en
prefLabel
Importance of pH control in the management of GERD.
@ast
Importance of pH control in the management of GERD.
@en
P1476
Importance of pH control in the management of GERD.
@en
P2093
P304
P356
10.1001/ARCHINTE.159.7.649
P407
P577
1999-04-01T00:00:00Z